Regeneron Pharmaceuticals, Inc. (FRA:RGO)
513.60
+3.20 (0.63%)
Last updated: May 13, 2025
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of €54.70 billion as of May 13, 2025. Its market cap has decreased by -39.02% in one year.
Market Cap
54.70B
Enterprise Value
41.28B
Revenue
13.03B
Ranking
n/a
PE Ratio
13.14
Stock Price
€513.60
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 131.41M to 54.70B, an increase of 41,524.61%. That is a compound annual growth rate of 20.17%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 305.24B |
Siemens Aktiengesellschaft | 167.30B |
Deutsche Telekom AG | 157.96B |
Allianz SE | 139.42B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 77.76B |
Rheinmetall AG | 77.10B |
Siemens Energy AG | 59.07B |
Merck KGaA | 53.63B |